Skip to main content
. 2024 Jun 5;20(1):2351584. doi: 10.1080/21645515.2024.2351584

Table 1.

Characteristics of the participants at baseline (modified exposed set).

Characteristic RZV group
N = 2965
Placebo group
N = 2991
Total
N = 5956
Age (years) at first vaccination
Mean (±SD) 62.4 (±7.8) 62.4 (±7.8) 62.4 (±7.8)
Sex, n (%)
Male 1163 (39.2) 1160 (38.8) 2323 (39.0)
Female 1802 (60.8) 1831 (61.2) 3633 (61.0)
Geographic ancestry, n (%)
Asian/East Asian heritage 2965 (100) 2991 (100) 5956 (100)
Age strata, n (%)
50–69 years of age 2330 (78.6) 2360 (78.9) 4690 (78.7)
≥ 70 years of age 635 (21.4) 631 (21.1) 1266 (21.3)

RZV group, participants receiving the adjuvanted recombinant zoster vaccine; placebo group, participants receiving placebo; N, total number of participants; SD, standard deviation; n (%), number (and percentage) of participants in each category.